Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.18 USD
Change Today 0.00 / 0.00%
Volume 113.9K
OCLS On Other Exchanges
OCLS is not on other exchanges.
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by OCULUS INNOVATIVE SCIENCES I (OCLS) in the last 6 months

Announced 03/13/15
Ruthigen, Inc.

Pulmatrix, Inc. entered into an agreement and plan of merger to acquire Ruthigen, Inc. (NasdaqCM:RTGN) in a reverse merger transaction on March 13, 2015. As part of consideration, each outstanding share of Pulmatrix common stock will be converted into 0.148187124066461 of one share of Ruthigen common stock. Immediately following the merger, Pulmatrix stockholders are expected to own approximately 81% of the outstanding capital stock of Ruthigen. For a period of twelve ...
Read More

OCLS's price was unchanged after the transaction was announced on 03/13/15.
Investor / Buyer
Pulmatrix, Inc.
Creditor / Lender
Marlin Capital Investments, LLC
Oculus Innovative Sciences, Inc.
Financial Advisor
Cassel Salpeter & Co., LLC
Dawson James Securities, Inc.
Legal Advisor
Grushko & Mittman

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCLS:US $1.18 USD 0.00

OCLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,800 JPY -4.00
Henry Schein Inc $139.40 USD +0.72
Integra LifeSciences Holdings Corp $60.79 USD +0.25
Patterson Cos Inc $46.39 USD +0.45
Smith & Nephew PLC 1,163 GBp +29.00
View Industry Companies

Industry Analysis


Industry Average

Valuation OCLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.3x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCULUS INNOVATIVE SCIENCES I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at